How Often Do Patients with ASCVD Achieve Target LDL-C?

Opinion
Video

A panel of clinical pharmacists introduce themselves and discuss how LDL cholesterol target achievement compares with guideline goals for patients with ASCVD who are treated with maximally tolerated statin monotherapy.

Related Videos
A panel of 5 experts on ASCVD
A panel of 5 experts on ASCVD
Video 2 - "Identifying Contraindications Before Administering RSV Vaccines"
Video 1 - "Preventing RSV in Adults: Current Vaccination Options"
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
Video 2 - "Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care"
Video 1 - "Identifying and Screening for Hepatic Encephalopathy Risk Factors"
Related Content
Managing Pulmonary Arterial Hypertension: Diagnosis, Classification, and Treatment Strategies

Managing Pulmonary Arterial Hypertension: Diagnosis, Classification, and Treatment Strategies

April 30th 2024
Article
Salt in wooden bowl on dark stone table. | Image Credit: Milan - stock.adobe.com

Study Finds Many Individuals With Cardiovascular Disease Consume Twice Daily Recommendation of Sodium

April 22nd 2024
Article
Semaglutide's New Indication Highlights Growing Role of GLP-1 Receptor Agonists

Semaglutide's New Indication Highlights Growing Role of GLP-1 Receptor Agonists

April 16th 2024
Article
SGLT-2 Inhibitors Associated with Reduced Hyperkalemia in Patients With Heart Failure

SGLT-2 Inhibitors Associated with Reduced Hyperkalemia in Patients With Heart Failure

April 15th 2024
Article
3d illustration of human heart and cardiogram on futuristic blue background. | Image Credit: Artem - stock.adobe.com

Real-World Data on Mavacamten Builds on Clinical, Safety Profile

April 15th 2024
Article
Empagliflozin Shows 10% Relative Risk Reduction in Time to First Hospitalization Due to Heart Failure

Empagliflozin Shows 10% Relative Risk Reduction in Time to First Hospitalization Due to Heart Failure

April 8th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.